We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$509M
AUM Growth
+$26M
(+5.4%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASRT
Assertio
ASRT
|
+$3.68M |
| 2 |
Red Robin
RRGB
|
+$3.46M |
| 3 |
Intapp
INTA
|
+$3.34M |
| 4 |
O-I Glass
OI
|
+$3.16M |
| 5 |
PDF Solutions
PDFS
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$4.8M |
| 2 |
Target Hospitality
TH
|
+$4.6M |
| 3 |
PDS Biotechnology
PDSB
|
+$4.36M |
| 4 |
Digi International
DGII
|
+$4.3M |
| 5 |
KLX Energy Services
KLXE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25% |
| 2 | Technology | 21.39% |
| 3 | Industrials | 20.38% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Energy | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Progress Software
PRGS
$1.77B
| $1.25M | 0.25% |
+21,811
| New | +$1.22M |
|
|
FL
202
DELISTED
Foot Locker
FL
| $1.25M | 0.25% |
+31,481
| New | +$1.32M |
|
203
MYR Group
MYRG
$5.28B
| $1.25M | 0.25% |
+9,911
| New | +$1.07M |
|
|
LUCK
204
Lucky Strike Entertainment
LUCK
$922M
| $1.25M | 0.25% |
+73,587
| New | +$1.09M |
|
|
AMK
205
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.24M | 0.24% |
+39,319
| New | +$1.1M |
|
|
SUP
206
DELISTED
Superior Industries International
SUP
| $1.21M | 0.24% |
+243,671
| New | +$1.34M |
|
207
Broadwind
BWEN
$111M
| $1.2M | 0.24% |
+313,204
| New | +$1.33M |
|
208
Cavco Industries
CVCO
$4.52B
| $1.19M | 0.23% |
+3,754
| New | +$1.04M |
|
209
Flux Power
FLUX
$11.1M
| $1.19M | 0.23% |
245,284
| – | – |
|
210
McGrath RentCorp
MGRC
$2.99B
| $1.19M | 0.23% |
12,731
+6
| +0% | +$593 |
|
211
Ocular Therapeutix
OCUL
$2B
| $1.18M | 0.23% |
+224,211
| New | +$1.06M |
|
|
MRNS
212
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.18M | 0.23% |
+170,901
| New | +$1.07M |
|
213
Life Time Group Holdings
LTH
$9.76B
| $1.17M | 0.23% |
+73,318
| New | +$1.26M |
|
214
Terex
TEX
$7.72B
| $1.17M | 0.23% |
+24,138
| New | +$1.23M |
|
215
CVD Equipment Corp
CVV
$60.1M
| $1.17M | 0.23% |
+87,734
| New | +$990K |
|
216
Kinsale Capital Group
KNSL
$8.58B
| $1.16M | 0.23% |
3,875
+429
| +12% | +$125K |
|
|
HAYN
217
DELISTED
Haynes International, Inc.
HAYN
| $1.16M | 0.23% |
23,079
| – | – |
|
218
Penumbra
PEN
$12.8B
| $1.15M | 0.23% |
4,135
-1,454
| -26% | -$371K |
|
|
SOVO
219
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.14M | 0.22% |
+68,476
| New | +$962K |
|
|
KDNY
220
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.13M | 0.22% |
48,875
-53,132
| -52% | -$1.27M |
|
221
OneSpan
OSPN
$610M
| $1.11M | 0.22% |
+63,202
| New | +$946K |
|
222
Oric Pharmaceuticals
ORIC
$1.35B
| $1.09M | 0.21% |
190,455
| – | – |
|
223
Crane NXT
CXT
$3.04B
| $1.08M | 0.21% |
+27,517
| New | +$1.09M |
|
224
Nerdy
NRDY
$96.6M
| $1.08M | 0.21% |
+257,655
| New | +$788K |
|
225
Commercial Vehicle Group
CVGI
$148M
| $1.07M | 0.21% |
+146,276
| New | +$1.11M |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q1 2023 Portfolio in Review
As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.
- EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
- EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
- EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
- EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
- EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
- EAM Investors opened 139 new positions and closed 144 in Q1 2023.
- EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.
Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.